1. Home
  2. EXAS vs DAY Comparison

EXAS vs DAY Comparison

Compare EXAS & DAY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EXAS
  • DAY
  • Stock Information
  • Founded
  • EXAS 1995
  • DAY 1992
  • Country
  • EXAS United States
  • DAY United States
  • Employees
  • EXAS N/A
  • DAY N/A
  • Industry
  • EXAS Medical Specialities
  • DAY
  • Sector
  • EXAS Health Care
  • DAY
  • Exchange
  • EXAS Nasdaq
  • DAY NYSE
  • Market Cap
  • EXAS 10.7B
  • DAY 9.5B
  • IPO Year
  • EXAS N/A
  • DAY 2018
  • Fundamental
  • Price
  • EXAS $54.28
  • DAY $56.47
  • Analyst Decision
  • EXAS Strong Buy
  • DAY Buy
  • Analyst Count
  • EXAS 20
  • DAY 13
  • Target Price
  • EXAS $70.16
  • DAY $72.23
  • AVG Volume (30 Days)
  • EXAS 2.8M
  • DAY 1.8M
  • Earning Date
  • EXAS 07-30-2025
  • DAY 07-30-2025
  • Dividend Yield
  • EXAS N/A
  • DAY N/A
  • EPS Growth
  • EXAS N/A
  • DAY N/A
  • EPS
  • EXAS N/A
  • DAY 0.16
  • Revenue
  • EXAS $2,828,128,000.00
  • DAY $1,810,300,000.00
  • Revenue This Year
  • EXAS $14.58
  • DAY $11.02
  • Revenue Next Year
  • EXAS $12.75
  • DAY $11.46
  • P/E Ratio
  • EXAS N/A
  • DAY $350.98
  • Revenue Growth
  • EXAS 11.57
  • DAY 14.97
  • 52 Week Low
  • EXAS $39.97
  • DAY $47.08
  • 52 Week High
  • EXAS $72.83
  • DAY $82.69
  • Technical
  • Relative Strength Index (RSI)
  • EXAS 53.90
  • DAY 46.57
  • Support Level
  • EXAS $50.19
  • DAY $54.36
  • Resistance Level
  • EXAS $57.40
  • DAY $58.22
  • Average True Range (ATR)
  • EXAS 2.17
  • DAY 1.49
  • MACD
  • EXAS -0.11
  • DAY -0.27
  • Stochastic Oscillator
  • EXAS 56.43
  • DAY 31.12

About EXAS Exact Sciences Corporation

Exact Sciences, headquartered in Madison, Wisconsin, provides cancer screening and diagnostic test products in the United States and internationally. Exact's Cologuard screening test is a noninvasive stool-based DNA test for colorectal cancer. The company also competes in the precision oncology market with Oncotype DX, a suite of tissue-based genomic tests for estimating recurrence risk and likelihood of benefit from chemotherapy for breast and colon cancer, and OncoExTra, a liquid-based comprehensive genomic profiling test. It is also developing liquid biopsy tests for molecular residual disease, colorectal cancer screening, and multicancer screening.

About DAY DAYFORCE INC

Dayforce is a global technology company providing cloud-based human capital management solutions for large businesses looking to manage their payroll, tax, benefits, and talent intelligence. The company primarily services customers in the US with its flagship Dayforce platform but also services customers in select European countries as well as Australia and New Zealand. Dayforce services the Canadian HCM market with its Powerpay platform that specifically targets customers with less than 100 employees. As of fiscal 2024, the Dayforce platform accounted for almost 80% of companywide revenue and had 6,876 clients representing approximately 7.62 million employees.

Share on Social Networks: